Bristol-Myers Squibb Co - Company Profile
Powered by
All the data and insights you need on Bristol-Myers Squibb Co in one report.
- Save hours of research time and resources with
our up-to-date Bristol-Myers Squibb Co Strategy Report
- Understand Bristol-Myers Squibb Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBristol-Myers Squibb Catalyst Calendar
Proactively evaluate Bristol-Myers Squibb Co’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Bristol-Myers Squibb Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
23 Aug 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
23 Aug 2019 | Phase III Trial Initiation | Almac Group Ltd; Celgene Corp; Impact Biomedicines Inc; Xinji Pharmaceutical Consulting (Shanghai) Co Ltd | - | fedratinib | Oncology | Myelofibrosis; Polycythemia Vera; Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF); Post-Polycythemia Vera Myelofibrosis (PPV-MF) | Clinical Trial Registry |
16 Aug 2019 | Phase III Trial Completion | Bristol-Myers Squibb Co; Ono Pharmaceutical Co Ltd | 4528; BMY | carboplatin; cisplatin; ipilimumab; nivolumab; paclitaxel | Oncology | Non-Small Cell Lung Cancer; Squamous Non-Small Cell Lung Cancer | Company Press Release |
14 Aug 2019 | Phase III Trial Initiation | Bristol-Myers Squibb Co; Hassman Research Institute LLC; LCC Medical Research Institute LLC; MAC Clinical Research Ltd; Ora Inc; PMG Research Inc; Radiant Research Inc; Synexus Clinical Research Ltd | BMY | deucravacitinib | Immunology | Plaque Psoriasis (Psoriasis Vulgaris); Psoriasis | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer